|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.05.26 - 15:06
|
Invenra Accelerates Commercial Strategy with Appointment of Chief Commercial Officer (Business Wire)
|
|
|
Company names Nancy J. Sandy CCO to drive global growth of its multispecific antibody platformMADISON, Wis.--(BUSINESS WIRE)--Invenra, Inc., a biotechnology company pioneering multispecific antibody therapeutics, today announced the appointment of Nancy J. Sandy as Chief Commercial Officer. The hire marks a significant step in the Invenra strategy to bring its expanding platform portfolio, including its B-Body® bispecific and newly launched T-Body™ trispecific antibody platforms, to pharmaceutical and biotech partners worldwide.
Invenra enters this next chapter with strong momentum. The company's collaboration partner Exelixis has advanced a bispecific antibody into Phase 1 clinical trials, the T-Body™ platform launched in 2025 to broad industry interest, and recent partnerships with Orion, Xcellon Biologics, and Twist Bioscience underscore growing global demand for Invenra capabilities. Sandy's appointment positions the company to scale these opportunities with dedicated commercial leadership for ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.05.26 - 14:06
|
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
|
|
|
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of 101,931 restricted stock units (“RSUs”) and up to 13,348 performance stock units (“PSUs”), will be granted to 53 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist's Amended and Restated Inducement Equity Incentive Plan and related form of restricted stock unit award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).
The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with Twist, pur...
|
|
|
|
|
|
|
|
|
|
|
04.05.26 - 13:18
|
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results (Business Wire)
|
|
|
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal second quarter 2026 earnings report and the investor presentation, or click https://investors.twistbioscience.com/events-and-presentations.
The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company's business. The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company's Investor Relations website or by clickin...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
